First Wave BioPharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$15,794,983 over the previous period. Total operating expenses were $15,741,553.

Profit Margin

First Wave BioPharma, Inc. (NASDAQ:FWBI): Profit margin
2015 0 -5.93M
2016 0 -14.59M
2017 0 -11.09M
2018 0 -13.53M
2019 0 -15.61M
2020 0 -38.72M
2021 0 -59.07M
2022 0 -16.58M
2023 0 -15.79M

FWBI Income Statement (2015 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
000000000
Cost of revenue
29.27K106.20K537.4K571.14K976.98K0000
Gross profit
-29.27K-106.20K-537.4K-571.14K-976.98K0000
Operating exp.
Research and development
5.03M691.25K38.32M19.13M8.68M4.98M2.39M2.49M1.39M
Selling and marketing
-29.27K00000000
Total operating expenses
15.74M12.67M56.70M26.43M14.74M13.43M10.08M6.62M4.72M
Operating income
-15.77M-12.67M-59.05M-26.43M-14.74M-13.43M-10.22M-6.32M-4.72M
Other income (expenses), net
-24.15K-1.95M519.03K-6.23M-433.93K-210K-875.19K-2.02M-1.20M
Income before tax
-15.79M-14.62M-58.53M-32.67M-15.17M-13.53M-11.09M-14.59M-5.93M
Income tax expense
-41.95M540.33K6.05M433.93K-108.15K875.19K5.93M1.58M
Net income
-15.79M-16.58M-59.07M-38.72M-15.61M-13.53M-11.09M-14.59M-5.93M
Earnings per share
Basic EPS
-46.96-461.72-27.79K-57.19K-29.23K-1.84K-2.19K-4.71K-1.29K
Diluted EPS
-46.96-461.72-27.79K-57.19K-29.23K-1.84K-2.19K-4.71K-1.26K
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source